NeuroX1 Inc.

NeuroX1 Inc.

Biotechnology Research

Austin, TX 1,859 followers

Creating the next generation of therapeutics for neurodegenerative disorders with our proprietary generative AI platform

About us

NeuroX1 is developing a target ID and drug discovery platform leveraging proprietary generative AI algorithms to create the next generation of therapeutics for neurological disorders. Our early-stage pipeline consists of several pre-clinical assets partnered with a variety of pharma companies and institutions.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Austin, TX
Type
Privately Held
Founded
2021
Specialties
generative drug discovery, biotechnology, neurology, neurodegenerative, rare disease, pediatric rare disease, AI, neuroscience, cancer, brain, generativeAI, Alzheimer's, Parkinson's, preclinical, MS, big pharma, partnerships, target ID, generative drugs, novel drugs, novel small molecules, future of drug discovery, inhibitors, neurosurgery, neural networks, platform technology, drug discovery platform, computational chemistry, computational biology, and target discovery

Locations

Employees at NeuroX1 Inc.

Updates

Similar pages

Browse jobs

Funding

NeuroX1 Inc. 3 total rounds

Last Round

Seed

US$ 220.0K

See more info on crunchbase